0001169245-18-000001.txt : 20180910 0001169245-18-000001.hdr.sgml : 20180910 20180907180230 ACCESSION NUMBER: 0001169245-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180910 DATE AS OF CHANGE: 20180907 EFFECTIVENESS DATE: 20180910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320911 FILM NUMBER: 181061013 BUSINESS ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-535-8861 MAIL ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 D 1 primary_doc.xml X0708 D LIVE 0001169245 PhaseBio Pharmaceuticals Inc One Great Valley Parkway Suite30 Malvern PA PENNSYLVANIA 19355 (610) 981-6500 DELAWARE Phase Biosciences Inc DT BIOSCIENCES INC Corporation true Jonathan Mow c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Clay Thorp c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Director Linda Tufts c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Director Justin Klein c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Director Tyrell Rivers c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Director Bibhash Mukhopadhyay c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Director Nancy Hutson c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Director Caroline Loewy c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Director John Sharp c/o PhaseBio Pharmaceuticals, Inc. One Great Valley Parkway, Suite 30 Malvern PA PENNSYLVANIA 19355 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2018-08-27 false true true true true Offer and sale of Series D Preferred Stock and warrants to purchase Series C-1 Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof. false 0 32125000 25998130 6126870 Total amount sold includes the value of cancelled indebtedness formerly held by certain purchasers in the aggregate principal amount of $8,085,000.00. false 20 0 0 0 false PhaseBio Pharmaceuticals Inc /s/ John Sharp John Sharp Chief Financial Officer 2018-09-07